Weight Gain and Schizophrenia Case Study

Open, View, and/or
Download this Document

Total Length: 1000 words ( 3 double-spaced pages)

Total Sources: 3

Page 1 of 3

Particularly after her PANSS test results, the client in this case has been diagnosed with schizophrenia, paranoid type, in which positive symptoms like delusions are prevalent. The purpose of this paper is to clarify three key psychopharmacological treatment decisions made on behalf of the client. Goals of all three decisions are symptom reduction and the promotion of the client's mental health and psychosocial functioning.

Decision

The decision was to give the patient Invega Sustenna (paliperidone palmitate) 234 mg intramuscular X1 followed by 156 mg intramuscular on day 4 and monthly thereafter, instead of either Zyprexa (olanzapine) or Abilify. The reasoning is based primarily on the fact that Invega Sustenna is a long-acting injectable with fewer compliance complications than orally administered drugs. Although Abilify has been available as a long-acting injectable, Invega Sustenna is recommended in this case because it presents fewer side effects than either Zyprexa or Abilify, particularly those the client has been concerned about such as weight gain (Khanna et al., 2016). Moreover, Invega Sustenna is a second-generation antipsychotic known to be "better tolerated and have fewer adverse neurological side effects" than first-generation drugs (Park, et al., 2013, p. 651).

The client returned to the clinic for follow-up four weeks after the initial injection of Invega Sustenna.

Stuck Writing Your "Weight Gain and Schizophrenia" Case Study?

View All Our Example Weight Gain and Schizophrenia Case Study

Have A Custom Example Essay Written

The PANSS was re-administered and the client's score decreased by 25%, revealing improvement. The client reports no troublesome side effects from the medication, although she complains of immediate pain at the injection site that lasts for several hours as well as some weight gain. However, neither of these are serious complications. The husband has agreed to take the client for further injections. It is believed that the switch from orally administered antipsychotics will be beneficial for this client, and it is strongly recommended that the client stay with Invega Sustenna given the promising initial results of the PANSS test.

Decision 2

Because the client expressed concern over not being able to sit or walk comfortably after the injection, it was recommended that the administering nurse inject at the deltoid site instead. As pain at the injection site is a concern due to the need to maintain patient compliance with the medication schedule, switching the site should not be a problem.

This decision worked well, as the client directly told the nurses that the pain was much less problematic at the arm site. However, the client has gained more weight -- up again from the first injection to now a total of 4.5 pounds over two months. The client.....

Show More ⇣

     Open the full completed essay and source list


OR

     Order a one-of-a-kind custom essay on this topic


sample essay writing service

Cite This Resource:

Latest APA Format (6th edition)

Copy Reference
"Weight Gain And Schizophrenia" (2017, January 07) Retrieved June 4, 2026, from
https://www.aceyourpaper.com/essays/weight-gain-schizophrenia-2164105

Latest MLA Format (8th edition)

Copy Reference
"Weight Gain And Schizophrenia" 07 January 2017. Web.4 June. 2026. <
https://www.aceyourpaper.com/essays/weight-gain-schizophrenia-2164105>

Latest Chicago Format (16th edition)

Copy Reference
"Weight Gain And Schizophrenia", 07 January 2017, Accessed.4 June. 2026,
https://www.aceyourpaper.com/essays/weight-gain-schizophrenia-2164105
   

Open, View, and/or
Download this Document
order custom essay example